A prognostic model for survival in chronic lymphocytic leukaemia based on p53 expression

Francis J. Giles, B. Nebiyou Bekele, Susan O'Brien, Jorge E. Cortes, Srdan Verstovsek, Maria Balerdi, Marwan Yared, Xian Zhou, Hagop M. Kantarjian, Michael J. Keating, Peter Thall, Maher Albitar

Research output: Contribution to journalArticle

Abstract

As the abnormal expression of p53 protein is prognostically significant in some human cancers, its significance in patients with B-cell chronic lymphocytic leukaemia (CLL) was assessed. Two investigators evaluated the percentage of bone marrow mononuclear cells that stained for p53, using biopsies stained with anti-p53 monoclonal antibody (DO-7), and graded the degree of staining (0, +, ++, +++). Samples from a cohort of 90 patients with CLL were studied (median age 60 years, range 30-89 years; 57 patients were (63%) previously untreated, 22 patients (24%) had received one or two prior regimens, 11 patients had received (12%) three to seven regimens. The overall percentage of cells positive for p53 staining was a median of 43 (range 1-88). No investigator effect was detected either in overall percentage cells rated p53 positive or on the degree of staining (Pearson's correlation coefficient 0.980, P-value <0.001). A Cox proportional hazards model showed that the percentage of ++ and +++ p53-positive cells correlated with various prognostic factors in CLL (P < 0.0001). A multivariate model incorporating prior therapy, Rai stage, beta2 microglobulin (β2M) and p53 expression showed that only the percentage of p53-positive cells and β2M were predictive of survival, and enabled the development of a highly predictive model of survival based on these two parameters.

Original languageEnglish (US)
Pages (from-to)578-585
Number of pages8
JournalBritish Journal of Haematology
Volume121
Issue number4
DOIs
StatePublished - May 1 2003
Externally publishedYes

Fingerprint

B-Cell Chronic Lymphocytic Leukemia
Survival
Staining and Labeling
Research Personnel
Proportional Hazards Models
Bone Marrow Cells
Biopsy
Neoplasms
Proteins

Keywords

  • Chronic lymphocytic leukaemia
  • Immunoperoxidase
  • p53
  • Prognosis
  • Survival

ASJC Scopus subject areas

  • Hematology

Cite this

A prognostic model for survival in chronic lymphocytic leukaemia based on p53 expression. / Giles, Francis J.; Bekele, B. Nebiyou; O'Brien, Susan; Cortes, Jorge E.; Verstovsek, Srdan; Balerdi, Maria; Yared, Marwan; Zhou, Xian; Kantarjian, Hagop M.; Keating, Michael J.; Thall, Peter; Albitar, Maher.

In: British Journal of Haematology, Vol. 121, No. 4, 01.05.2003, p. 578-585.

Research output: Contribution to journalArticle

Giles, FJ, Bekele, BN, O'Brien, S, Cortes, JE, Verstovsek, S, Balerdi, M, Yared, M, Zhou, X, Kantarjian, HM, Keating, MJ, Thall, P & Albitar, M 2003, 'A prognostic model for survival in chronic lymphocytic leukaemia based on p53 expression', British Journal of Haematology, vol. 121, no. 4, pp. 578-585. https://doi.org/10.1046/j.1365-2141.2003.04306.x
Giles, Francis J. ; Bekele, B. Nebiyou ; O'Brien, Susan ; Cortes, Jorge E. ; Verstovsek, Srdan ; Balerdi, Maria ; Yared, Marwan ; Zhou, Xian ; Kantarjian, Hagop M. ; Keating, Michael J. ; Thall, Peter ; Albitar, Maher. / A prognostic model for survival in chronic lymphocytic leukaemia based on p53 expression. In: British Journal of Haematology. 2003 ; Vol. 121, No. 4. pp. 578-585.
@article{450452d0def24bb4ac20c6745cabd213,
title = "A prognostic model for survival in chronic lymphocytic leukaemia based on p53 expression",
abstract = "As the abnormal expression of p53 protein is prognostically significant in some human cancers, its significance in patients with B-cell chronic lymphocytic leukaemia (CLL) was assessed. Two investigators evaluated the percentage of bone marrow mononuclear cells that stained for p53, using biopsies stained with anti-p53 monoclonal antibody (DO-7), and graded the degree of staining (0, +, ++, +++). Samples from a cohort of 90 patients with CLL were studied (median age 60 years, range 30-89 years; 57 patients were (63{\%}) previously untreated, 22 patients (24{\%}) had received one or two prior regimens, 11 patients had received (12{\%}) three to seven regimens. The overall percentage of cells positive for p53 staining was a median of 43 (range 1-88). No investigator effect was detected either in overall percentage cells rated p53 positive or on the degree of staining (Pearson's correlation coefficient 0.980, P-value <0.001). A Cox proportional hazards model showed that the percentage of ++ and +++ p53-positive cells correlated with various prognostic factors in CLL (P < 0.0001). A multivariate model incorporating prior therapy, Rai stage, beta2 microglobulin (β2M) and p53 expression showed that only the percentage of p53-positive cells and β2M were predictive of survival, and enabled the development of a highly predictive model of survival based on these two parameters.",
keywords = "Chronic lymphocytic leukaemia, Immunoperoxidase, p53, Prognosis, Survival",
author = "Giles, {Francis J.} and Bekele, {B. Nebiyou} and Susan O'Brien and Cortes, {Jorge E.} and Srdan Verstovsek and Maria Balerdi and Marwan Yared and Xian Zhou and Kantarjian, {Hagop M.} and Keating, {Michael J.} and Peter Thall and Maher Albitar",
year = "2003",
month = "5",
day = "1",
doi = "10.1046/j.1365-2141.2003.04306.x",
language = "English (US)",
volume = "121",
pages = "578--585",
journal = "British Journal of Haematology",
issn = "0007-1048",
publisher = "Wiley-Blackwell",
number = "4",

}

TY - JOUR

T1 - A prognostic model for survival in chronic lymphocytic leukaemia based on p53 expression

AU - Giles, Francis J.

AU - Bekele, B. Nebiyou

AU - O'Brien, Susan

AU - Cortes, Jorge E.

AU - Verstovsek, Srdan

AU - Balerdi, Maria

AU - Yared, Marwan

AU - Zhou, Xian

AU - Kantarjian, Hagop M.

AU - Keating, Michael J.

AU - Thall, Peter

AU - Albitar, Maher

PY - 2003/5/1

Y1 - 2003/5/1

N2 - As the abnormal expression of p53 protein is prognostically significant in some human cancers, its significance in patients with B-cell chronic lymphocytic leukaemia (CLL) was assessed. Two investigators evaluated the percentage of bone marrow mononuclear cells that stained for p53, using biopsies stained with anti-p53 monoclonal antibody (DO-7), and graded the degree of staining (0, +, ++, +++). Samples from a cohort of 90 patients with CLL were studied (median age 60 years, range 30-89 years; 57 patients were (63%) previously untreated, 22 patients (24%) had received one or two prior regimens, 11 patients had received (12%) three to seven regimens. The overall percentage of cells positive for p53 staining was a median of 43 (range 1-88). No investigator effect was detected either in overall percentage cells rated p53 positive or on the degree of staining (Pearson's correlation coefficient 0.980, P-value <0.001). A Cox proportional hazards model showed that the percentage of ++ and +++ p53-positive cells correlated with various prognostic factors in CLL (P < 0.0001). A multivariate model incorporating prior therapy, Rai stage, beta2 microglobulin (β2M) and p53 expression showed that only the percentage of p53-positive cells and β2M were predictive of survival, and enabled the development of a highly predictive model of survival based on these two parameters.

AB - As the abnormal expression of p53 protein is prognostically significant in some human cancers, its significance in patients with B-cell chronic lymphocytic leukaemia (CLL) was assessed. Two investigators evaluated the percentage of bone marrow mononuclear cells that stained for p53, using biopsies stained with anti-p53 monoclonal antibody (DO-7), and graded the degree of staining (0, +, ++, +++). Samples from a cohort of 90 patients with CLL were studied (median age 60 years, range 30-89 years; 57 patients were (63%) previously untreated, 22 patients (24%) had received one or two prior regimens, 11 patients had received (12%) three to seven regimens. The overall percentage of cells positive for p53 staining was a median of 43 (range 1-88). No investigator effect was detected either in overall percentage cells rated p53 positive or on the degree of staining (Pearson's correlation coefficient 0.980, P-value <0.001). A Cox proportional hazards model showed that the percentage of ++ and +++ p53-positive cells correlated with various prognostic factors in CLL (P < 0.0001). A multivariate model incorporating prior therapy, Rai stage, beta2 microglobulin (β2M) and p53 expression showed that only the percentage of p53-positive cells and β2M were predictive of survival, and enabled the development of a highly predictive model of survival based on these two parameters.

KW - Chronic lymphocytic leukaemia

KW - Immunoperoxidase

KW - p53

KW - Prognosis

KW - Survival

UR - http://www.scopus.com/inward/record.url?scp=0037716441&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037716441&partnerID=8YFLogxK

U2 - 10.1046/j.1365-2141.2003.04306.x

DO - 10.1046/j.1365-2141.2003.04306.x

M3 - Article

C2 - 12752098

AN - SCOPUS:0037716441

VL - 121

SP - 578

EP - 585

JO - British Journal of Haematology

JF - British Journal of Haematology

SN - 0007-1048

IS - 4

ER -